Psychiatric treatment received by primary care patients with panic disorder with and without agoraphobia

Psychiatric Services

Volumn 60, Issue 6, 2009, Pages 823-830

  Marcks, Brook A ^a   Weisberg, Risa B ^a   Keller, Martin B ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGORAPHOBIA; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DRUG CHOICE; FEMALE; HEALTH CARE NEED; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANIC; PATIENT COMPLIANCE; PATIENT EDUCATION; PSYCHOTHERAPY;

EID: 66749147394     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.2009.60.6.823     Document Type: Article

References (51)

1. Kessler RC, Berglund P, Demler O, et al: Lifetime prevalence and age of onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62:593-602, 2005 (Pubitemid 40973434)
2. Kessler RC, Chiu WT, Demler O, et al: Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62:617-627, 2005 (Pubitemid 40973437)
3. Keller MB, Yonkers KA, Warshaw MG, et al: Remission and relapse in subjects with panic disorder and panic with agoraphobia. Journal of Nervous and Mental Disease 182:290-296, 1994
4. Bruce SE, Yonkers KA, Otto MW, et al: Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. American Journal of Psychiatry 162:1179-1187, 2005 (Pubitemid 40770702)
5. Francis JL, Weisberg RB, Dyck IR, et al: Characteristics and course of panic disorder and panic disorder with agoraphobia in primary care patients. Primary Care Companion to the Journal of Clinical Psychiatry 9:173-179, 2007 (Pubitemid 46878735)
6. Siegel L, Jones WC, Wilson JO: Economic and life consequences experienced by a group of individuals with panic disorder. Journal of Anxiety Disorders 4:201-211, 1990 (Pubitemid 20301971)
7. Leon AC, Portera L, Weissman M: The social costs of anxiety disorders. British Journal of Psychiatry 166(suppl 27):19-22, 1995
8. Roy-Byrne PP, Stein MB, Russo J, et al: Panic disorder in the primary care setting: comorbidity, disability, service utilization, and treatment. Journal of Clinical Psychiatry 60:492-499, 1999 (Pubitemid 29369808)
9. Stein MB, Roy-Byrne PP, Craske MG, et al: Functional impact of health utility of anxiety disorders in primary care outpatients. Medical Care 43:1164-1170, 2005
10. Klerman GL, Weissman M, Ouellette R, et al: Panic attacks in the community: social morbidity and health care utilization. JAMA 265:742-746, 1991
11. Sherbourne CD, Wells KB, Meredith LS, et al: Comorbid anxiety disorders and the functioning and well-being of chronically ill patients of general medical providers. Archives of General Psychiatry 53:889-895, 1996 (Pubitemid 126752201)
12. Mendlowicz MV, Stein MB: Quality of life in individuals with anxiety disorders. American Journal of Psychiatry 157:669-682, 2000 (Pubitemid 30249642)
13. Barsky AJ, Delamater BA, Orav JE: Panic disorder patients and their medical care. Psychosomatics 40:50-56, 1999 (Pubitemid 29056580)
14. Carrera M, Herran A, Ayuso-Mateos JL, et al: Quality of life in early phases of panic disorder: predictive factors. Journal of Affective Disorders 94:127-134, 2006 (Pubitemid 44093021)
15. Rees CS, Richards JC, Smith LM: Medical utilization and costs in panic disorder: a comparison with social phobia. Journal of Anxiety Disorders 12:421-435, 1998 (Pubitemid 28484838)
16. Katerndahl DA, Realini JP: Where do panic attack sufferers seek care? Journal of Family Practice 40:237-243, 1995
17. Leon AC, Olfson M, Portera L: Service utilization and expenditures for the treatment of panic disorder. General Hospital Psychiatry 19:82-88, 1997 (Pubitemid 27146815)
18. Kessler RC, Chui WT, Jin R, et al: The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Archives of General Psychiatry 63:415-424, 2006 (Pubitemid 43848298)
19. Katon W, Roy-Byrne PP: Panic disorder in the medically ill. Journal of Clinical Psychiatry 50:299-302, 1989 (Pubitemid 19212699)
20. Spitzer RL, Williams JB, Kroenke K, et al: Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME MD 1000 Study. JAMA 272:1749-1756, 1994 (Pubitemid 24372002)
21. Yelin E, Mathias S, Buesching D, et al: The impact of employment of an intervention to increase recognition of previously untreated anxiety among primary care physicians. Social Science and Medicine 42:1069-1075, 1996 (Pubitemid 126349996)
22. Roy-Byrne PP, Russo J, Dugdale DC, et al: Undertreatment of panic disorder in primary care: role of patient and physician characteristics. Journal of the American Board of Family Practice 15:443-450, 2002 (Pubitemid 44872679)
23. Weisberg RB, Dyck I, Culpepper L, et al: Psychiatric treatment in primary care patients with anxiety disorders: a comparison of care received from primary care providers and psychiatrists. American Journal of Psychiatry 164:276-282, 2007 (Pubitemid 46318566)
24. Swinson RP, Cox BJ, Woszczyna CB: Use of medical services and treatment for panic disorder with agoraphobia and for social phobia. Canadian Medical Association Journal 147:878-883, 1992
25. Goismann RM, Rogers MP, Steketee GS, et al: Utilization of behavioral methods in a multicenter anxiety disorders study. Journal of Clinical Psychiatry 54:213-218, 1993 (Pubitemid 23213596)
26. Yonkers K, Ellison J, Shera D, et al: Description of antipanic therapy in prospective longitudinal study. Journal of Clinical Psychopharmacology 16:223-232, 1996 (Pubitemid 26227920)
27. Boyer W: Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. International Clinical Psychopharmacology 10:45-49, 1995
28. Otto MW, Tuby KS, Gould RA, et al: An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder. American Journal of Psychiatry 158:1989-1992, 2001
29. Bakker A, van Balkom AJ, Spinhoven P: SSRIs vs TCAs in the treatment of panic disorder: a meta-analysis. Acta Psychiatrica Scandinavica 106:163-167, 2002
30. Mitte K: A meta-analysis of the efficacy of psycho- and-pharmacotherapy in panic disorder with and without agoraphobia. Journal of Affective Disorders 88:27-45, 2005 (Pubitemid 41160411)
31. Westen D, Morrison K: A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies. Journal of Consulting and Clinical Psychology 69:875-899, 2001 (Pubitemid 33140488)
32. Milrod B, Leon AC, Busch F, et al: A randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder. American Journal of Psychiatry 164:265-272, 2007 (Pubitemid 46318564)
33. Wang PS, Lane M, Olfson M, et al: Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Archives of General Psychiatry 62:629-640, 2005 (Pubitemid 40973438)
34. Sue S, Fujino DC, Hu L, et al: Community mental health services for ethnic minority groups: a test of the cultural responsiveness hypothesis. Journal of Consulting and Clinical Psychology 59:533-540, 1991
35. Green-Hennessy S, Hennessy KD: Demographic differences in medication use among individuals with self-reported major depression. Psychiatric Services 50:257-259, 1999 (Pubitemid 29069688)
36. Wells KB, Schoenbaum M, Unützer J, et al: Quality of care for primary care patients with depression in managed care. Archives of Family Medicine 8:529-536, 1999
37. Craske MG, Edlund MJ, Sullivan G, et al: Perceived unmet need for mental health treatment and barriers to care among patients with panic disorder. Psychiatric Services 56:988-994, 2005 (Pubitemid 41098739)
38. First MB, Spitzer RL, Gibbon M, et al: Structured Clinical Interview for the DSM-IV Axis I Disorders. New York, New York State Psychiatric Institute, Biometrics Research Department, 1996
39. Weisberg RB, Bruce SE, Machan JT, et al: Nonpsychiatric illness among primary care patients with trauma histories and posttraumatic stress disorder. Psychiatric Services 53:848-854, 2002 (Pubitemid 34742767)
40. Weisberg RB, Maki KB, Culpepper L, et al: Is anyone really MAD? The occurrence and course of mixed anxiety-depressive disorder in a sample of primary care patients. Journal of Nervous and Mental Disease 193:223-230, 2005 (Pubitemid 40504616)
41. Ventura J, Liberman RP, Green MF, et al: Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Research 79:163-173, 1998 (Pubitemid 28308489)
42. Keller MB, Warshaw MG, Dyck I, et al: LIFE-IV: The Longitudinal Interval Follow-up Evaluation for DSM-IV. Providence, RI, Brown University, Department of Psychiatry and Human Behavior, 1997
43. Warshaw MG, Keller MB, Stout RL: Reliability and validity of the Longitudinal Interval Follow-up Evaluation for assessing outcome of anxiety disorders. Journal of Psychiatric Research 28:531-545, 1994
44. Steketee G, Perry JC, Goisman RM, et al: The Psychosocial Treatments Interview for anxiety disorders: a method for assessing psychotherapeutic procedures in anxiety disorders. Journal of Psychotherapy Practice and Research 6:194-210, 1997 (Pubitemid 27290666)
45. SAS Procedure Guide, Version 9.1.3. Cary, NC, SAS Institute, 2006
46. Campbell-Sills L, Stein MB: Guideline Watch: Practice Guideline for the Treatment of Patients With Panic Disorder. Arlington, Va, American Psychiatric Association, 2006
47. Grant BF, Hasin DS, Stinson FS, et al: The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 67:363-374, 2006
48. Stein MB, Sherbourne CD, Craske MG, et al: Quality of care for primary care patients with anxiety disorders. American Journal of Psychiatry 161:2230-2237, 2004 (Pubitemid 39587288)
49. Marshall JR: Comorbidity and its effects on panic disorder. Bulletin of the Menninger Clinic 60(suppl l):A39-A53, 1996 (Pubitemid 26158292)
50. Oflson M, Pincus HA: Outpatient psychotherapy in the United States. I: volume, costs, and user characteristics. American Journal of Psychiatry 151:1281-1288, 1994
51. Wang PS, Aguilar-Gaxiola S, Alonso J, et al: Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet 370:841-850, 2007 (Pubitemid 47362343)